NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Sentiment Remains Cautious Amid Uncertainty Over US-Iran Peace Deal

The domestic stock market witnessed a sharp and sudden drop in the final hour of trade on Friday, 29 May, which dragged the benchmarks, the Sensex and the Nifty 50, down by over 1% each. Market sentiment remains cautious amid persistent uncertainty over the final contours of a potential US-Iran peace deal. While US President Donald Trump is expected to decide on a proposal to extend the ceasefire with Iran, media reports suggest that the two countries have yet to reach common ground on key issues, including the reopening of the Strait of Hormuz and Tehran's nuclear programme.

Experts say investors should avoid predicting the course of the market and focus on stock-specific opportunities. Pankaj Pandey, the head of research at ICICI Securities, recommends the following five stocks for the next one-two years.

Stock Picks for Long Term

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

StockPrevious CloseTarget PriceUpside Potential
Artemis Medicare Services₹273.36₹34024%
VA Tech Wabag₹1,527.80₹1,93026%
Tata Steel₹208.02₹27030%
Mahindra & Mahindra₹3,045.60₹4,00031%
Engineers India₹231.70₹31536%

Artemis Medicare Services is a healthcare venture launched by the promoters of the Apollo Tyres Group, commanding an industry-leading ARPOB of ₹82,435 per day. It derives nearly 32% revenues from international patients. The company is planning to almost triple the bed capacity from current levels of 700 beds to nearly 2,000+ beds in the next 3-4 years by brownfield expansion and O&M agreements.

VA Tech Wabag’s order backlog stood at a robust ₹17,235 crore at the end of FY26, growing 26% YoY and implying revenue visibility of more than 4 times FY26 revenue, significantly higher than the company’s internal threshold of maintaining order book at nearly 3 times annual revenue.

Tata Steel, one of India’s largest steel producers, delivered a healthy Q4FY26 performance with EBITDA gains of nearly ₹2,500 per tonne, supported by higher domestic steel prices. The company has guided for realisation improvement of nearly ₹6,000 per tonne in Q1FY27, likely to drive EBITDA gains of nearly ₹3,500 per tonne, the highest among domestic peers.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Mahindra & Mahindra (M&M) is a conglomerate with presence in auto, IT, financial services, etc., among others. It is India’s largest tractor manufacturer (43.6% FY26 market share) and second largest CV, second largest PV maker (28.2%, 14.2% FY26 market share).

Engineers India (EIL) ended FY26 with a record order book of nearly ₹15,109 crore (+29% YoY) led by strong consultancy inflows (nearly ₹6,010 crore) and large international wins, providing healthy execution visibility over the next 3-5 years.

Investor Takeaway

Investors should buy quality stocks on dips for long-term growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.